Polymedco Introduces Point Of Care Test For Recurrent Bladder Cancer Detection (Medical News Today) PDF Print

Polymedco, Inc. is pleased to announce the direct availability of the BTA stat(R) test from our sales force -- The BTA stat(R) test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.